<DOC>
	<DOCNO>NCT01942174</DOCNO>
	<brief_summary>To estimate rate immunological answer 1 month antipneumococcal vaccination conjugate vaccine Prevenar13 Â® patient suffer rheumatoid polyarthritis begin treatement methotrexate either time , either 1 month later .</brief_summary>
	<brief_title>VACcination In Methotrexate Treated Rheumatoid Arthritis Patients</brief_title>
	<detailed_description>Patients suffer rheumatoid polyarthritis increase risk develop infection compare general population , important mortality risk pneumococcus consider one major pathogenic agent . Antipneumcoccal vaccination recommend patient suffer chronic inflammatory rheumatism treat immunosuppressant . Methotrexate long term treatment use first intention rheumatoid polyarthritis . A recent study show decrease efficacity antipneumoccal vaccination patient suffer rheumatoid polyarthritis treat methotrexate . The tested hypothesis presence well vaccinal protection patient suffer rheumatoid polyarthritis 1 month antipneumococcal vaccination initiation methotrexate . The objective compare immunologic response antipneumococcal vaccination patient vaccinate time initiation methotrexate patient vaccinate 1 month begin treatment .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Adult ( &gt; 18 yea old ) suffer rheumatoid arthritis consider ACR/EULAR 2010 criterion Rheumatoid arthritis consider 3,2 &lt; DAS &lt; 5,1 Patient treat long term treatment stop treatment sulfasalazine , hydroxychloroquine methotrexate least 3 month Patient never treat biotherapy Patient never vaccinate pneumococcal Patient sign study consent form Patient ever treat leflunomide treat previously leflunomide ( last 3 month ) Patient currently treat methotrexate treat previously methotrexate ( last 3 month ) Contraindication methotrexate : renal insuffisance , alcoolic , chronic hepatisis , infectious condition , AIDS , hematological failure ( cytopeny ) , pregnancy , obesity , diabet , respiratory disease , gastric ulcer Contraindication corticotherapy Pregnancy pregancy wish Nursing Absence oral contraception woman childbearing age Patient age protect law et deprive liberty Subject refuse vaccinated pneumococcis agent Previous history vaccination allergy ( anaphylactic shok , Quincke oedema ... ) Gluten hypersensivity intolerance Other vaccination last month inclusion Ig perfusion last 3 month period study inclusion study duration Patient currently treat anticoagulant stop least 48h study inclusion hemostasis failure contraindicate muscular injection Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Antipneumococcal vaccination</keyword>
	<keyword>Methotrexate treatment</keyword>
</DOC>